Loading
Latest filing published 27 Apr 2023 for Cardiovascular Systems Inc, €1.4M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Stephen J. Rempe in Cardiovascular Systems Inc, where the filings describe the role as senior executive. Over a trading history stretching from 12 May 2021 to 27 April 2023, the count stands at 10 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 27 April 2023 with a transaction (€1.4M) in Cardiovascular Systems Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations